发明名称 |
Fibrosis inhibitor |
摘要 |
[Object] The main object of the present invention is to provide a fibrosis inhibitor.;[Solving Means] The present invention relates to a fibrosis inhibitor containing the heterocyclic derivative represented by the following general formula (1) or a pharmaceutically acceptable salt thereof as an active ingredient;;
In the formula (1),
R1 and R2 are the same or different and each represents an optionally substituted aryl;R3 and R4 are the same or different and each represents hydrogen atom or alkyl;R5 represents hydrogen atom, alkyl or halogen atom;Y represents N or N→O;A represents NR6, and R6 represents hydrogen atom, alkyl, etc.;D represents alkylene or alkenylene which is optionally substituted with hydroxy;E represents phenylene or a single bond;G represents O, S, etc.; andQ represents carboxy, alkoxycarbonyl, etc. |
申请公布号 |
USRE46364(E1) |
申请公布日期 |
2017.04.11 |
申请号 |
US201615155202 |
申请日期 |
2016.05.16 |
申请人 |
NIPPON SHINYAKU CO., LTD. |
发明人 |
Murakami Koji;Toramoto Takuya |
分类号 |
A61K31/4965;C07D241/02;C07D241/20 |
主分类号 |
A61K31/4965 |
代理机构 |
|
代理人 |
|
主权项 |
1. A method for treating interstitial pneumonia comprising administering a fibrosis inhibitor containing 2-{4-[N-(5,6-diphenylpyrazin-2-yl)-N-isopropylamino]butyloxy}acetic acid, 2-{4[N-(5,6-diphenylpyrazin-2-yl)-N-isopropylamino]butyloxy}-N-(methylsulfonyl)acetamide or a pharmaceutically acceptable salt thereof as an active ingredient to a patient in need of such treatment. |
地址 |
Kyoto JP |